BioSpace News Archive

Crohn’s Disease Drug Market Research Report on Industry Dynamics With Growth Forecast To 2027

The global Crohn’s disease drug market is forecast to reach USD 13.72 Billion by 2027, according to a new report by Reports and Data.

August 25, 2022
·
7 min read
Robot Assisted Surgical Systems Market Growth, Key Players Analysis on Presents and Future Statistics till 2027

The Global Robot Assisted Surgical Systems Market is forecast to reach USD 17.80 billion by 2027.

August 25, 2022
·
6 min read
Microcarrier Market Size Worth USD 4431.12 Million in 2030 | Emergen Research

The global microcarrier market size was USD 1833.77 Million in 2021 and is expected to register a revenue CAGR of 10.3% during the forecast period, according to latest analysis by Emergen Research.

August 25, 2022
·
6 min read
Cell-based Assays Market Size, Share, Growth, Trends, Report 2022-2030

According to Vision Research Reports, the global cell-based assay market size was estimated USD 11.87 billion in 2021 and is expected to hit around USD 28.48 billion by 2030, with a registered CAGR of 8.5% from 2022 to 2030.

August 25, 2022
·
6 min read
Healthcare Companion Robots Market Size, Growth, Trends | Report 2022-2030

The global healthcare companion robots market is expected to witness growth in the coming years owing to the introduction of advanced technology, growing disposable income and increasing healthcare infrastructure.

August 25, 2022
·
3 min read
Business

Lytix Biopharma: Second quarter and first half of 2022 results

Lytix Biopharma, a Norwegian immune-oncology company, releases its second quarter and first half 2022 results - New encouraging clinical data.

August 25, 2022
·
4 min read
Genetown

Immuneering Announces Participation in September 2022 Investor Conferences

Immuneering Corporation announced that management will participate in two September investor conferences to share commentary around the Company’s pipeline, platform, and business strategy.

August 25, 2022
·
3 min read
Business

Tigermed Reports 2022 Interim Result with Strong Financial Growth

Hangzhou Tigermed Consulting Co., Ltd. announced its interim results for the first half of 2022, ended June 30, 2022.

August 25, 2022
·
9 min read
Pharm Country

Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection

Century Therapeutics, Inc. announced today that the company has been notified by the U.S. Food and Drug Administration (FDA) that the Company’s ELiPSE-1 clinical study may proceed to assess CNTY-101 in patients with relapsed or refractory CD19 positive B-cell malignancies.

August 25, 2022
·
8 min read
Pharm Country

Ordaōs Raises $5 Million in Seed to Accelerate Drug Design and Discovery

Ordaōs today announced the completion of $5M in seed financing to aid in new product development and expand partner acquisition efforts.

August 25, 2022
·
3 min read